KalshiComprobar disponibilidadKYC requerido2% de comisiónDatos de resolución verificadosCalibración aceptableProbabilidad implícita actual
COVID-19 14%Líder entre 6 opciones
Calidad del mercado
52 / 100
Calidad mediaVolumen 24h
0,9 €
Liquidez
5,1 mil €
Liquidez mediaSpread
2.0 pt
Spread estrechoDatos de mercado
Actualizado hace 10 minutos
27 ene 26, 1:00 UTC1 ene 27, 15:00 UTC
Tendencias
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
The anti-vax market: Which vaccines become less available in the US, 2025-2026
Manifold MarketsWill GiveWell recommend a grant to support breastfeeding promotion before 2027?
Manifold MarketsWill FDA approve more than 10 new mRNA based vaccines before 2028?
Manifold MarketsMeasles cases in U.S. in 2026?
PolymarketNew pandemic in 2026?
PolymarketHantavirus pandemic in 2026?
PolymarketReglas
If the CDC ends its recommendation completely for the COVID-19 vaccine before Jan 1, 2027, then the market resolves to Yes.
Liquida mediante:CDC
- Merely reducing the categories of persons that it recommends the vaccine for, without reducing those categories to zero, is not encompassed by the Payout Criterion.
- If the CDC ends its recommendation completely for the Dengue vaccine before Jan 1, 2027, then the market resolves to Yes.
- If the CDC ends its recommendation completely for the the named outcome vaccine before Jan 1, 2027, then the market resolves to Yes.
- If the CDC ends its recommendation completely for the Influenza vaccine before Jan 1, 2027, then the market resolves to Yes.
- If the CDC ends its recommendation completely for the Polio vaccine before Jan 1, 2027, then the market resolves to Yes.